| Name | ethyl 1-methylpyridin-1-ium-4-carboxylate,iodide |
|---|---|
| Synonyms |
PyridiniuM, 4-(ethoxycbonyl)-1-Methyl-, iodide
1-methyl-4-ethoxycarbonylpyridinium iodide ethyl N-methylisonicotinatium iodide 4-Aethoxycarbonyl-1-methyl-pyridinium,Jodid 4-(Ethoxycbonyl)-1-methylpyridin-1-ium iodide Ethyl isonicotinate methiodide 4-(Ethoxycarbonyl)-1-methylpyridin-1-ium iodide 4-ETHOXYCBONYL-1-METHYL-PYRIDINIUM, IODIDE 4-Ethoxycarbonyl-1-methyl-pyridinium iodide 1-methyl-4-ethoxycbonylpyridinium iodide |
| Molecular Formula | C9H12INO2 |
|---|---|
| Molecular Weight | 293.10200 |
| Exact Mass | 292.99100 |
| PSA | 30.18000 |
| HS Code | 2933399090 |
|---|
|
~99%
10129-59-6 |
| Literature: AstraZeneca AB; NPS PHARMACEUTICALS, INC. Patent: US2007/259862 A1, 2007 ; Location in patent: Page/Page column 28 ; US 20070259862 A1 |
| Precursor 2 | |
|---|---|
| DownStream 4 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |